etoposide has been researched along with Triple Negative Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-David, Y; Ed Chung, P; He, Z; Liang, LN; Liu, S; Long, Q; Xiao, X; Xu, M; Yang, C; Yao, Y; Zacksenhaus, E | 1 |
| Cai, L; Cao, M; Chen, X; Chen, Y; He, T; Hu, J; Huang, J; Li, C; Liu, W; Liu, X; Lu, H; Pang, H; Sun, L; Sun, Y; Xing, Y; Yan, S; Zhang, N; Zhao, D; Zhao, L | 1 |
| Chiu, HW; Hong, CW; Huang, WJ; Wang, BJ; Wang, YC; Wang, YJ; Wu, YH; Yeh, YL | 1 |
| Cai, J; Cai, Y; Li, G; Liang, Q; Zhang, Y; Zhao, B | 1 |
| Bharatam, PV; Das, S; Kundu, CN; Nayak, A; Nayak, D; Sethy, C; Siddharth, S; Tripathi, N | 1 |
| Cao, Y; Chen, X; Chen, Y; Li, X; Ni, D; Shen, K; Tang, J; Wei, Z; Wu, K; Xie, X; Ye, G; Zhang, C; Zheng, H | 1 |
| Blomen, V; Brummelkamp, TR; Hoogstraat, M; Janssen, L; Lips, EH; Neefjes, J; Pang, B; Qiao, X; van der Zanden, SY; Wessels, L; Wijdeven, RH | 1 |
| Bratta, M; Candeloro, G; D'Orazi, V; Fumagalli, LA; Pasta, V; Rea, S; Recchia, F; Rosselli, M | 1 |
| Chen, L; Cui, H; Deng, H; Fang, J; Guo, H; Kuang, P; Wang, X; Zhao, L | 1 |
2 trial(s) available for etoposide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.
Topics: Antineoplastic Agents; Etoposide; Humans; Hypertension; Triple Negative Breast Neoplasms | 2023 |
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Receptor, ErbB-2; Taxoids; Treatment Outcome; Triple Negative Breast Neoplasms | 2013 |
7 other study(ies) available for etoposide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Molecular Structure; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2018 |
A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
Topics: Acridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carrier Proteins; Cell Line, Tumor; DNA Damage; DNA End-Joining Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Proteasome Endopeptidase Complex; Proteolysis; Time Factors; Topoisomerase II Inhibitors; Triple Negative Breast Neoplasms; Ubiquitin-Protein Ligases; Ubiquitination | 2017 |
The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Drug Interactions; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Triple Negative Breast Neoplasms | 2017 |
Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Protein Binding; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Capecitabine; Carcinoma; Chromosomal Proteins, Non-Histone; CRISPR-Cas Systems; Cyclophosphamide; DNA Helicases; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genome-Wide Association Study; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Neoplasm Proteins; Nuclear Proteins; RNA Interference; RNA, Small Interfering; Sarcoma; SMARCB1 Protein; Taxoids; Topoisomerase II Inhibitors; Topotecan; Transcription Factors; Triple Negative Breast Neoplasms | 2015 |
Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Interleukin-2; Isotretinoin; Leuprolide; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Triple Negative Breast Neoplasms | 2015 |
Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Cisplatin; Culture Media; Dose-Response Relationship, Drug; Etoposide; Female; Glutaminase; Glutamine; Humans; Immunoblotting; Sulfides; Thiadiazoles; Triple Negative Breast Neoplasms | 2016 |